Literature DB >> 28623522

H3 K27M mutations are extremely rare in posterior fossa group A ependymoma.

Scott Ryall1, Miguel Guzman2, Samer K Elbabaa3, Betty Luu4, Stephen C Mack5, Michal Zapotocky6, Michael D Taylor1,4,7, Cynthia Hawkins1,4,8, Vijay Ramaswamy9,10.   

Abstract

BACKGROUND: Mutations in the tail of histone H3 (K27M) are frequently found in pediatric midline high-grade glioma's but have rarely been reported in other malignancies. Recently, recurrent somatic nucleotide variants in histone H3 (H3 K27M) have been reported in group A posterior fossa ependymoma (EPN_PFA), an entity previously described to have no recurrent mutations. However, the true incidence of H3 K27M mutations in EPN_PFA is unknown.
METHODS: In order to discern the frequency of K27M mutations in histone H3 in EPN_PFA, we analyzed 151 EPN_PFA previously profiled with genome-wide methylation arrays using a validated droplet digital PCR assay.
RESULTS: We identified only 1 case out of 151 EPN_PFA harboring the K27M mutation indicating that histone mutations are extremely rare in EPN_PFA. Morphologically, this single mutated case is clearly consistent with an ependymoma, and the presence of the K27M mutation was confirmed using immunohistochemistry. DISCUSSION: K27M mutations are extremely rare in EPN_PFA. Routine evaluation of K27M mutations in EPN_PFA is of limited utility, and is unlikely to have any bearing on prognosis and/or future risk stratification.

Entities:  

Keywords:  Ependymoma; Histone; K27M; PFA

Mesh:

Substances:

Year:  2017        PMID: 28623522     DOI: 10.1007/s00381-017-3481-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  22 in total

1.  Evidence of H3 K27M mutations in posterior fossa ependymomas.

Authors:  Marco Gessi; David Capper; Felix Sahm; Kristin Huang; Andreas von Deimling; Stephan Tippelt; Gudrun Fleischhack; Daniel Scherbaum; Joachim Alfer; Björn-Ole Juhnke; Katja von Hoff; Stefan Rutkowski; Monika Warmuth-Metz; Lukas Chavez; Stefan M Pfister; Torsten Pietsch; David T W Jones; Dominik Sturm
Journal:  Acta Neuropathol       Date:  2016-08-18       Impact factor: 17.088

Review 2.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

3.  Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

Authors:  Hendrik Witt; Stephen C Mack; Marina Ryzhova; Sebastian Bender; Martin Sill; Ruth Isserlin; Axel Benner; Thomas Hielscher; Till Milde; Marc Remke; David T W Jones; Paul A Northcott; Livia Garzia; Kelsey C Bertrand; Andrea Wittmann; Yuan Yao; Stephen S Roberts; Luca Massimi; Tim Van Meter; William A Weiss; Nalin Gupta; Wiesia Grajkowska; Boleslaw Lach; Yoon-Jae Cho; Andreas von Deimling; Andreas E Kulozik; Olaf Witt; Gary D Bader; Cynthia E Hawkins; Uri Tabori; Abhijit Guha; James T Rutka; Peter Lichter; Andrey Korshunov; Michael D Taylor; Stefan M Pfister
Journal:  Cancer Cell       Date:  2011-08-16       Impact factor: 31.743

4.  Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.

Authors:  Peter W Lewis; Manuel M Müller; Matthew S Koletsky; Francisco Cordero; Shu Lin; Laura A Banaszynski; Benjamin A Garcia; Tom W Muir; Oren J Becher; C David Allis
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

5.  K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas.

Authors:  Dong-Anh Khuong-Quang; Pawel Buczkowicz; Patricia Rakopoulos; Xiao-Yang Liu; Adam M Fontebasso; Eric Bouffet; Ute Bartels; Steffen Albrecht; Jeremy Schwartzentruber; Louis Letourneau; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Genevieve Bourret; Pierre Lepage; Adam Fleming; Peter Lichter; Marcel Kool; Andreas von Deimling; Dominik Sturm; Andrey Korshunov; Damien Faury; David T Jones; Jacek Majewski; Stefan M Pfister; Nada Jabado; Cynthia Hawkins
Journal:  Acta Neuropathol       Date:  2012-06-03       Impact factor: 17.088

6.  Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.

Authors:  Rintaro Hashizume; Noemi Andor; Yuichiro Ihara; Robin Lerner; Haiyun Gan; Xiaoyue Chen; Dong Fang; Xi Huang; Maxwell W Tom; Vy Ngo; David Solomon; Sabine Mueller; Pamela L Paris; Zhiguo Zhang; Claudia Petritsch; Nalin Gupta; Todd A Waldman; C David James
Journal:  Nat Med       Date:  2014-11-17       Impact factor: 53.440

7.  Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.

Authors:  Mark Barszczyk; Pawel Buczkowicz; Pedro Castelo-Branco; Stephen C Mack; Vijay Ramaswamy; Joshua Mangerel; Sameer Agnihotri; Marc Remke; Brian Golbourn; Sanja Pajovic; Cynthia Elizabeth; Man Yu; Betty Luu; Andrew Morrison; Jennifer Adamski; Kathleen Nethery-Brokx; Xiao-Nan Li; Timothy Van Meter; Peter B Dirks; James T Rutka; Michael D Taylor; Uri Tabori; Cynthia Hawkins
Journal:  Acta Neuropathol       Date:  2014-08-06       Impact factor: 17.088

8.  Treatment implications of posterior fossa ependymoma subgroups.

Authors:  Vijay Ramaswamy; Michael D Taylor
Journal:  Chin J Cancer       Date:  2016-11-15

9.  Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.

Authors:  Pawel Buczkowicz; Christine Hoeman; Patricia Rakopoulos; Sanja Pajovic; Louis Letourneau; Misko Dzamba; Andrew Morrison; Peter Lewis; Eric Bouffet; Ute Bartels; Jennifer Zuccaro; Sameer Agnihotri; Scott Ryall; Mark Barszczyk; Yevgen Chornenkyy; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Francisco Cordero; Pedro Castelo-Branco; Joshua Mangerel; Uri Tabori; King Ching Ho; Annie Huang; Kathryn R Taylor; Alan Mackay; Anne E Bendel; Javad Nazarian; Jason R Fangusaro; Matthias A Karajannis; David Zagzag; Nicholas K Foreman; Andrew Donson; Julia V Hegert; Amy Smith; Jennifer Chan; Lucy Lafay-Cousin; Sandra Dunn; Juliette Hukin; Chris Dunham; Katrin Scheinemann; Jean Michaud; Shayna Zelcer; David Ramsay; Jason Cain; Cameron Brennan; Mark M Souweidane; Chris Jones; C David Allis; Michael Brudno; Oren Becher; Cynthia Hawkins
Journal:  Nat Genet       Date:  2014-04-06       Impact factor: 38.330

10.  Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.

Authors:  Scott Ryall; Rahul Krishnatry; Anthony Arnoldo; Pawel Buczkowicz; Matthew Mistry; Robert Siddaway; Cino Ling; Sanja Pajovic; Man Yu; Joshua B Rubin; Juliette Hukin; Paul Steinbok; Ute Bartels; Eric Bouffet; Uri Tabori; Cynthia Hawkins
Journal:  Acta Neuropathol Commun       Date:  2016-08-31       Impact factor: 7.801

View more
  16 in total

1.  EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.

Authors:  Jens-Martin Hübner; Torsten Müller; Dimitris N Papageorgiou; Monika Mauermann; Jeroen Krijgsveld; Robert B Russell; David W Ellison; Stefan M Pfister; Kristian W Pajtler; Marcel Kool
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

2.  Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.

Authors:  Fausto J Rodriguez; Jacqueline A Brosnan-Cashman; Sariah J Allen; M Adelita Vizcaino; Caterina Giannini; Sandra Camelo-Piragua; Milad Webb; Marcus Matsushita; Nitin Wadhwani; Abeer Tabbarah; Dima Hamideh; Liqun Jiang; Liam Chen; Leonidas D Arvanitis; Hussein H Alnajar; John R Barber; Alicia Rodríguez-Velasco; Brent Orr; Christopher M Heaphy
Journal:  Brain Pathol       Date:  2018-10-17       Impact factor: 6.508

3.  Is H3K27me3 status really a strong prognostic indicator for pediatric posterior fossa ependymomas? A single surgeon, single center experience.

Authors:  Bahattin Tanrıkulu; Ayça Erşen Danyeli; M Memet Özek
Journal:  Childs Nerv Syst       Date:  2020-02-05       Impact factor: 1.475

4.  Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.

Authors:  Kristian W Pajtler; Ji Wen; Martin Sill; Tong Lin; Wilda Orisme; Bo Tang; Jens-Martin Hübner; Vijay Ramaswamy; Sujuan Jia; James D Dalton; Kelly Haupfear; Hazel A Rogers; Chandanamali Punchihewa; Ryan Lee; John Easton; Gang Wu; Timothy A Ritzmann; Rebecca Chapman; Lukas Chavez; Fredrick A Boop; Paul Klimo; Noah D Sabin; Robert Ogg; Stephen C Mack; Brian D Freibaum; Hong Joo Kim; Hendrik Witt; David T W Jones; Baohan Vo; Amar Gajjar; Stan Pounds; Arzu Onar-Thomas; Martine F Roussel; Jinghui Zhang; J Paul Taylor; Thomas E Merchant; Richard Grundy; Ruth G Tatevossian; Michael D Taylor; Stefan M Pfister; Andrey Korshunov; Marcel Kool; David W Ellison
Journal:  Acta Neuropathol       Date:  2018-06-16       Impact factor: 17.088

Review 5.  Put away your microscopes: the ependymoma molecular era has begun.

Authors:  Stephen C Mack; Michael D Taylor
Journal:  Curr Opin Oncol       Date:  2017-11       Impact factor: 3.645

6.  Heterogeneity within the PF-EPN-B ependymoma subgroup.

Authors:  Florence M G Cavalli; Jens-Martin Hübner; Tanvi Sharma; Betty Luu; Martin Sill; Michal Zapotocky; Stephen C Mack; Hendrik Witt; Tong Lin; David J H Shih; Ben Ho; Mariarita Santi; Lyndsey Emery; Juliette Hukin; Christopher Dunham; Roger E McLendon; Eric S Lipp; Sridharan Gururangan; Andrew Grossbach; Pim French; Johan M Kros; Marie-Lise C van Veelen; Amulya A Nageswara Rao; Caterina Giannini; Sarah Leary; Shin Jung; Claudia C Faria; Jaume Mora; Ulrich Schüller; Marta M Alonso; Jennifer A Chan; Almos Klekner; Lola B Chambless; Eugene I Hwang; Maura Massimino; Charles G Eberhart; Matthias A Karajannis; Benjamin Lu; Linda M Liau; Massimo Zollo; Veronica Ferrucci; Carlos Carlotti; Daniela P C Tirapelli; Uri Tabori; Eric Bouffet; Marina Ryzhova; David W Ellison; Thomas E Merchant; Mark R Gilbert; Terri S Armstrong; Andrey Korshunov; Stefan M Pfister; Michael D Taylor; Kenneth Aldape; Kristian W Pajtler; Marcel Kool; Vijay Ramaswamy
Journal:  Acta Neuropathol       Date:  2018-07-17       Impact factor: 17.088

7.  An H3F3A K27M-mutation in a sonic hedgehog medulloblastoma.

Authors:  Matthias Dottermusch; Nesrin Uksul; Ulrich J Knappe; Bernhard Erdlenbruch; Annika K Wefers
Journal:  Brain Pathol       Date:  2021-11-07       Impact factor: 7.611

8.  Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.

Authors:  Vinicius Fernandes Oliveira; Graziella Ribeiro De Sousa; Antonio Carlos Dos Santos; Fabiano Pinto Saggioro; Helio Rubens Machado; Ricardo Santos de Oliveira; Luiz Gonzaga Tone; Elvis Terci Valera
Journal:  Childs Nerv Syst       Date:  2020-08-07       Impact factor: 1.475

9.  Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas.

Authors:  Annamaria Biczok; Felix L Strübing; Julia M Eder; Rupert Egensperger; Oliver Schnell; Stefan Zausinger; Julia E Neumann; Jochen Herms; Joerg-Christian Tonn; Mario M Dorostkar
Journal:  Acta Neuropathol Commun       Date:  2021-06-30       Impact factor: 7.801

Review 10.  Polycomb repressive complex 2 in the driver's seat of childhood and young adult brain tumours.

Authors:  Brian Krug; Ashot S Harutyunyan; Shriya Deshmukh; Nada Jabado
Journal:  Trends Cell Biol       Date:  2021-06-03       Impact factor: 21.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.